Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation (Resistance)

This study has been completed.

Sponsor:

Information provided by:

Achillion Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00312039

First received: April 5, 2006

Last updated: October 30, 2007

Last verified: October 2007

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Estimated Primary Completion Date:	No date given